Refine your search
4 trials found for Bladder cancer
Recruiting
Not yet recruiting
2 trials recruiting
Be6A Clinical Trials
Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.
Recruiting
NCT05911295
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Urothelial Carcinoma
Male or Female
18+ years
310study location(s)
Recruiting
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous
Male or Female
18+ years
131study location(s)
Recruiting
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Male or Female
18+ years
188study location(s)
Recruiting
NCT05902494
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Urothelial Carcinoma
Male or Female
18+ years
23study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.